Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 2
Author(s): Gustav Akk
Affiliation:
Export Options
About this article
Cite this article as:
Akk Gustav, Meet Our Editorial Board Member, Current Neuropharmacology 2015; 13 (2) . https://dx.doi.org/10.2174/1570159X1302150525143440
DOI https://dx.doi.org/10.2174/1570159X1302150525143440 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
“Self-Antigenic Universe” and Tuberculosis Vaccine Development
Current Pharmacogenomics and Personalized Medicine Effects of Early Maternal Separation on Biobehavioral and Neuropathological Markers of Alzheimer's Disease in Adult Male Rats
Current Alzheimer Research The Fetal Origins of Obesity: Early Origins of Altered Food Intake
Endocrine, Metabolic & Immune Disorders - Drug Targets Coumarin and Derivates as Lipid Lowering Agents
Current Topics in Medicinal Chemistry Novel, Acidic CCR2 Receptor Antagonists: Lead Optimization
Letters in Drug Design & Discovery The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
Mini-Reviews in Medicinal Chemistry Neurofunctional Correlates of Theory of Mind Deficits in Schizophrenia
Current Topics in Medicinal Chemistry CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome
Current Pharmaceutical Design Edging Toward Personalized Medicine
Current Pharmacogenomics Environmental Enrichment as a Positive Behavioral Intervention Across the Lifespan
Current Neuropharmacology Genetic Lipodystrophies: Models for Insulin Resistance
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Proteasome Modulation in Brain: A New Target for Anti-Aging Drugs?
Central Nervous System Agents in Medicinal Chemistry Genomics of Addiction
Current Psychiatry Reviews Tuning the Electronic Properties by Width and Length Modifications of Narrow- Diameter Carbon Nanotubes for Nanomedicine
Current Medicinal Chemistry Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
Current Psychopharmacology Study of the Relationships between COVID-19, Associated Diseases, and Vitamins
Coronaviruses Metabotropic Glutamate Receptors and Interacting Proteins: Evolving Drug Targets
Current Drug Targets Novel Targets for Drugs in Schizophrenia
CNS & Neurological Disorders - Drug Targets Development and Validation of HPLC Methods for the Determination of CYP2D6 and CYP3A4 Activities
Current Pharmaceutical Analysis